Society guideline links: Hemolytic uremic syndrome in children

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Thrombotic microangiopathies (TTP, HUS, and related disorders)".)

International

●An international consensus approach to the management of atypical hemolytic uremic syndrome in children (2016)

United States

●Centers for Disease Control and Prevention (CDC): Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories (2009)

Europe

●European Paediatric Study Group for HUS: Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome (2009)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Highly specialised technologies guidance on eculizumab for treating atypical haemolytic uraemic syndrome (2015)

●Renal Association (RA), British Committee for Standards in Haematology (BCSH), British Transplantation Society (BTS): Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom (2009)

Australia–New Zealand

●New South Wales Ministry of Health (NSW Health): Haemolytic uraemic syndrome (HUS) and shigatoxigenic E. coli infections (STEC) control guideline (2012, revised 2016)